India's Pharma Exports Exceed $28 Billion
Analysis based on 20 articles · First reported Apr 04, 2026 · Last updated Apr 04, 2026
The robust growth in India's pharmaceutical exports, driven by strong demand from markets like the United States and Europe, signals positive prospects for the global pharmaceutical industry. This trend is expected to boost the stock prices of Indian pharmaceutical companies and potentially influence related sectors.
India's pharmaceutical exports have reached over USD 28 billion by February of the current financial year, marking a 5% growth compared to the previous year. The sector, currently valued at USD 60 billion, is projected to grow to USD 130 billion by 2030. This growth is attributed to strong performance in formulations, biologicals, vaccines, and AYUSH products, despite global challenges like pricing pressures and trade volatility. The Pharmaceuticals Export Promotion Council of India (Pharmexcil), led by K. Raja Bhanu and Namit Joshi, aims for USD 65 billion in exports by 2030 through policy prioritization, market diversification, increased FDI, and improved regulatory efficiency. The United States accounts for 34% of India's pharmaceutical exports, followed by Europe at 19%.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard